Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma.

David G SuDijana DjureinovicDavid A Schoenfeld Bernadette Marquez-Nostra Kelly OlinoLucia JilaveanuHarriet M Kluger

Published in: JCO precision oncology (2024)

Our data suggest that MC1R might be a valuable drug target in aggressive melanoma. Additional studies are warranted to determine its functional significance in melanoma progression and its utility as a predictive biomarker in patients receiving MC1R-directed therapies.

Keyphrases

skin cancer
electronic health record
emergency department